Summary by Futu AI
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively reported beneficial ownership of 5,855,597 shares of Tonix Pharmaceuticals Holding Corp. common stock, representing approximately 9.99% of the company's outstanding shares. The filing, made with the United States Securities and Exchange Commission, indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The ownership percentage is based on the current total of 58,614,593 outstanding shares of Tonix Pharmaceuticals, as reported in the company's Form 8-K filed on January 25, 2024. The report also includes a statement that the reporting persons hold warrants to purchase additional shares, but due to the terms of the Warrants, they can only exercise enough to maintain a 9.9% ownership stake. The filing was completed on February 14, 2024, by Jason Bragg, Chief Financial Officer of Alyeska Investment Group, L.P. and Alyeska Fund GP, LLC, and Anand Parekh individually.